The Economic Times

Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations

Maharashtra FDA cancelled Cipla's Pune unit drug sale licences. Serious irregularities in storage and recall procedures were cited by the regulator. The company failed to fully comply with market recall directions for Reactin Plus Tablets. Further non-compliance was discovered in the unit's distribution and sales system.